Early Donor Cell Chimerism After Allogeneic Transplantation Predicts Probability of Relapse for Patients Treated for Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodgkin's Lymphoma (NHL).

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - 2013
EventAmerican Society of Hematology – 55th Annual Meeting and Exposition - New Orleans, LA
Duration: Jan 1 2013 → …

Conference

ConferenceAmerican Society of Hematology – 55th Annual Meeting and Exposition
Period1/1/13 → …

Disciplines

  • Medicine and Health Sciences

Cite this